
Developer of AI-Powered Dental Imaging Analysis Systems
AI+ New Drug R&D Company
The deep integration of digital intelligence technologies represented by AI with the pharmaceuticals and healthcare industry is unleashing tremendous industrial development potential.
On November 30, Zhongguancun (Chaoyang) Digital Medical Industry Park was officially inaugurated. According to the Zhongguancun Chaoyang Park Management Committee, the park will focus on three leading industries: "artificial intelligence + diagnosis and treatment," intelligent medical devices, and digital health management. It will also develop three distinctive industries: "AI + drug research and development," digital traditional Chinese medicine, and health data elements, while nurturing multiple future sectors such as brain-computer brain science, cell and gene therapy, and regenerative medicine. By 2030, the park aims to become a world-class digital healthcare innovation hub, attracting and cultivating over 500 enterprises in the digital healthcare industry chain, driving the formation of an industrial scale worth hundreds of billions.
The First Batch of Key AI Medical Enterprises Settled In
In the United States, Thailand, and Saudi Arabia, stepping into some local dental clinics, an AI super assistant will aid dentists in analyzing patients' oral images, identifying issues, and designing treatment plans. The development team behind this "AI Dentist" hails from Beijing, China.
Dentists are a highly valuable and scarce talent resource. Beijing Feather Medical Cabbage Information Technology Co., Ltd.'s cutting-edge oral AI solution can quickly identify and analyze oral images, detecting nearly 40 types of oral diseases and conditions within 5 seconds, assisting doctors in improving consultation efficiency.
Zhao Manlan, Chief Operating Officer of Beijing Feather Medical Cabbage Information Technology Co., Ltd., said that taking dental implants as an example, a dentist needs to undergo years of study and practice implanting hundreds of teeth before being able to independently and accurately place implants in the missing tooth position. If done incorrectly, it may result in the implant penetrating the jawbone, causing a medical accident. Now, doctors only need to click the mouse a few times in the Feather Medical Cabbage Dental AI system to complete tasks such as 3D segmentation, 3D reconstruction, virtual tooth arrangement, implant planning, and surgical guide generation. The treatment design work that originally took hours is now shortened to minutes, increasing efficiency a hundredfold. The implant guides produced based on the fully automatic AI implant guide design system and 3D printing technology can assist doctors in completing precise dental implant procedures.
Driven by artificial intelligence technology, the field of new drug development, which once had long development cycles, high technical difficulty, and was costly in terms of manpower and funding, has now entered a new era of rapid advancement. With Inflygent Pharmaceutical AI's self-developed AI + new drug development platform "PharmaBrain," researchers are able to perform precise computational predictions for the design and screening of compounds, significantly enhancing the level of innovative drug development and early-stage success rates from the outset. It is reported that the success rate of AI-driven drug design by the Inflygent Pharmaceutical AI team has reached 3 to 10 times the industry average.
On the same day, Beijing Feather Medical Cabbage Information Technology Co., Ltd., Inflygent Pharmaceutical AI Technology Co., Ltd., and a group of other key digital healthcare enterprises officially signed agreements to become the first batch of companies入驻中关村(朝阳)数字医疗产业园.
Advantages of the Digital Healthcare Industry Chain Emerge
Beijing Feather Medical Cabbage Information Technology Co., Ltd., which promotes Chinese oral AI diagnosis and treatment technology globally, Inflygent Pharmaceutical AI, an AI pharmaceutical company aiming to develop original innovative drugs, Shuimu Keyi, which is pushing for the "from 0 to 1" breakthrough in the domestic production of high-end cryo-electron microscopy, and Zhongke Shangyi, which develops digital traditional Chinese medicine meridian treatment equipment... Represented by the first batch of companies入驻园区, China's digital healthcare industry is now running neck-and-neck with top global peers, advancing with Chinese original technologies at the forefront of the industry.
Thailand, the United States, Germany... Zhao Manlan's work schedule for this year and the coming months is packed with trips to visit clients and partners around the globe. "The company has just reached a collaboration with the American Dental Association this year and has also entered the Egyptian market. With the upcoming acquisition of China's first domestic oral artificial intelligence...Class III Medical Devices"The registration certificate will also usher in further development for the company in the Chinese market," said Zhao Manlan.
Currently, Feather Medical Cabbage's AIDental TechnologyThe products have been applied in dental medical institutions across more than 60 countries and regions worldwide, serving millions of patients with oral diseases. Recently, the innovative artificial intelligence orthodontics transformation project, developed in collaboration with Peking University School of Stomatology, has been implemented at the Chaoyang Digital Medical Innovation Port. Both parties will jointly develop an integrated smart orthodontic treatment solution that combines orthodontic medicine, biomechanics, material science, and artificial intelligence, striving to create a "unicorn" and leading enterprise in the global orthodontics field.
A relevant official from Chaoyang District introduced that the district has more than 200 digital healthcare enterprises and over 2,000 medical and health institutions. With a complete industrial chain and abundant application scenarios, it holds a significant advantage in the development of the digital healthcare industry.
A 10-billion-yuan industrial investment fund will be established.
More high-quality innovative companies are emerging.
The person in charge of Chaoyang Technology Group, the construction and operation party of Zhongguan Village (Chaoyang) Digital Medical Industrial Park, introduced that the industrial park will become a highland for the innovative development of the digital medical industry, consisting of a Digital Medical Innovation Port and a Technology Transformation Base. Among them, within the Digital Medical Innovation Port, the incubation and transformation area will provide start-up venues, shared facilities, investment and financing, and entrepreneurial guidance services according to enterprise needs. The professional technical service area will provide enterprises with common technology platforms such as concept verification and testing, and offer services ranging from prototype development, clinical trials, pilot verification, registration, to evidence-based evaluation.
Capital is the "lifeblood" of enterprise development. A relevant official from Zhongguan Village Chaoyang Park revealed that the Capital Development Group and Chaoyang District, in collaboration with social capital, are planning to establish a digital healthcare industry investment fund with an initial scale of 200 million yuan and a total scale of 1 billion yuan, focusing on the selection and investment of digital healthcare projects. Zhongguan Village Technology Service Company and Chaoyang District will also collaborate with social capital to plan the establishment of Rainforest Phase II Fund, with a focus on supporting the development of the digital healthcare industry.
Special Statement: The Intelligent Healthcare Network reproduces content from other websites for the purpose of conveying more information, not for profit. It does not signify agreement with or confirmation of the views or descriptions therein, and the content is for reference only. All rights reserved to the original authors; if there is any infringement, please contact us for deletion.
Any content sourced from the Smart Healthcare Network is original to the Smart Healthcare Network, and reprinting requires authorization.